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bHLHgene hlh-6 is expressed speciﬁcally in pharyngeal glands, one of ﬁve distinct
pharyngeal cell types. Expression of hlh-6 is controlled by a discrete set of cis-regulatory elements,
including a negative element called HRL1. Here we demonstrate that HRL1 is a functional binding site for
LAG-1, the CSL transcriptional effector of Notch in C. elegans, and that regulation of hlh-6 by LAG-1 is direct.
Regulation of hlh-6 by LAG-1 is strictly negative: removal of HRL1 or LAG-1 regulation results in ectopic
expression of hlh-6, but does not affect expression in pharyngeal glands. Furthermore, direct regulation of
hlh-6 expression does not appear to involve Notch signaling, contrary to the canonical mechanism by which
CSL factors regulate target genes. We also identify an additional cis-regulatory element in the hlh-6
promoter that, together with previously identiﬁed elements, is sufﬁcient to overcome repression by LAG-1
and activate hlh-6 expression in pharyngeal glands.
© 2008 Elsevier Inc. All rights reserved.IntroductionAn important challenge in developmental biology is to understand
how distinct cell fates are speciﬁed. The leading model proposes that
the combinatorial action of transcription factors speciﬁes distinct
cellular identities. These inputs must ultimately act to regulate the
expression of cell type-speciﬁc genes, thereby imparting identity to the
cell. Thus, oneway to understand cell speciﬁcation is to understand the
unique combination of transcription factors and their response
elements that generate cell type-speciﬁc expression of target genes.
The pharynx of Caenorhabditis elegans provides an excellent model
to study the speciﬁcation of cell fates in the context of a developing
organ. The pharynx consists of 80 cells, representing ﬁve different cell
types (muscles,marginal cells, neurons, epithelia and glands; Albertson
and Thomson, 1976). Speciﬁcation of all pharyngeal cells, regardless of
type, requires PHA-4, a forkhead box A (FoxA) transcription factor that
appears to directly regulate the expression of most or all pharyngeal
genes (Gaudet and Mango, 2002; Horner et al., 1998; Kalb et al., 1998).
Since PHA-4 is expressed in all pharyngeal cells, it likely acts in concert
with factors that (individually or in combination) are speciﬁc to each of
the pharyngeal cell types. While several additional pharyngeal
regulators has been identiﬁed (ceh-22, peb-1, pha-1, pha-2, and tbx-2),
these factors act broadly in the pharynx or in subsets of pharyngeal
muscles and there is no clear understanding of how the different
pharyngeal cell fates are speciﬁed (Morck et al., 2004; Okkema and Fire,and Molecular Biology, Faculty
l rights reserved.1994; Okkema et al., 1997; Roy Chowdhuri et al., 2006; Schnabel and
Schnabel,1990; Smith andMango, 2006; Thatcher et al., 2001).Wehave
been studying the development of gland cells of the pharynx by
examining the spatial regulation of gland-speciﬁc genes. One advan-
tage of C. elegans for this work is that gene regulatory sequences are
relatively short (Okkema and Krause, 2005), making it feasible to
identify the complete set of cis-regulatory elements controlling the
expression of a given gene.
We previously showed that expression of the C. elegans basic helix-
loop-helix transcription factor hlh-6 is speciﬁc to pharyngeal glands
(Figs. 1A and B). The speciﬁc pattern of hlh-6 expression is generated by
the combined action of discrete cis-regulatory elements that do not by
themselves exhibit gland-speciﬁc activity (Raharjo and Gaudet, 2007).
One cis-regulatory element is a PHA-4 binding site (PBShlh) that is
essential for hlh-6 expression. Thus, one component of hlh-6 regulation
is activation in an organ (pharynx)-speciﬁc manner. Expression of hlh-6
is further restricted to pharyngeal glands by the actions of two other cis-
regulatory elements, HRL1 and HRL2 (for hlh-6 Regulatory eLements 1
and 2). HRL2 is required for hlh-6promoter activity and acts in a lineage-
and/or position-speciﬁc manner. Speciﬁcally, the combination of PBShlh
and HRL2 activates reporter expression in posterior pharyngeal cells
(including glands) that are descendents of one of two blastomeres that
give rise to the pharynx (the MS blastomere; Sulston et al., 1983). The
third element, HRL1, has very little enhancer activity in combination
with either PBS or HRL2. Instead, HRL1 represses expression of hlh-6 in
non-gland cells. Thus, the combination of all three elements (PBS, HRL1
and HRL2) produces gland-speciﬁc expression. The gland-speciﬁc
expression of hlh-6 provides a clear example of howpromoters integrate
multiple broad transcriptional inputs to achieve cell type-speciﬁc
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trans-acting factors that bind to the sites in the hlh-6 promoter to bring
about gland-speciﬁc expression.
Here we describe the identiﬁcation of LAG-1, the C. elegans CSL (CBF,
Suppressor of Hairless, LAG-1) familymember, as the trans-acting factor
binding to HRL1 and repressing transcription of hlh-6. We demonstrate
that HRL1 represents a functional LAG-1 binding site (LBS). Typically,
CSL transcription factors are the downstream effectors of Notch
signaling (reviewed in Bray, 2006; Greenwald, 2005). CSL factors act
as default repressors of gene expression in the absence of Notch
signaling and as transcriptional activators in the presence of Notch
signaling. In C. elegans, the only established role for LAG-1 is as aFig. 1. HRL1 resembles the LAG-1/CSL binding sequence (LBS). (A) Diagram of the
pharynx showing the gland cell bodies: light grey cells are g1 glands, dark grey are g2
glands (modiﬁed from Albertson and Thomson, 1976). (B) Expression of hlh-6::YFP is
speciﬁc to pharyngeal glands, beginning in embryos and continuing to adulthood. The
animal shown here is an L3 larvae. The pharynx is outlined. Note the characteristic
projections from the posterior to anterior bulb. (C) Schematic of the minimal hlh-6
promoter (241 bp) showing critical cis-regulatory elements. Triangle indicates a PHA-4
binding site (PBS; TGTTTGC), black ovals represent occurrences of the two hlh-6
regulatory element 2 (HRL2; AATAAATA), white ovals represent the three HRL1
elements. (D) HRL1 sequences closely resemble the consensus LBS (Christensen et al.,
1996), where R = A or G, S = C or G and W = A or T. (E) HRL1b is conserved in four
nematode species: Ce = C. elegans, Cb = C. briggsae, Cr = C. remanei and Cbre = C.
brenneri. Promoter sequence from other species was identiﬁed using available genomic
tools (Dieterich and Sommer, 2008).transcriptional activator (Gupta and Sternberg, 2002; Neves et al., 2007;
Yooet al., 2004). In contrast, ourdatawithHRL1demonstrate that LAG-1
regulation of hlh-6 expression is limited to negative regulation in non-
gland cells, revealing a non-canonical use of a CSL factor as a strictly
negative regulator. Instead of LAG-1 responding to Notch signaling, we
show that the activities of the cis-regulatory elements PBS, HRL2 and a
newly identiﬁed site, HRL3, overlap in the pharyngeal glands and are
sufﬁcient to overcome default repression by LAG-1. These ﬁndings
expand our understanding of the different inputs required for cell type-
speciﬁc expression and suggest a novel role for LAG-1/CSL as a strictly
negative regulator of target gene expression, in contrast to its dual roles
as an activator and repressor of other known targets.
Materials and methods
Worm strains
Standard nematode handling conditions were used (Brenner,
1974). Strains used were wild type N2; JK1227: lag-1(q385)/dpy-13
(e184) unc-24(e138) III; and JK1313: lin-12(n941) glp-1(q46)/dpy-19
(e1259) unc-69(e587) III. lag-1 and lin-12 glp-1 animals were identiﬁed
from JK1127 and JK1313, respectively, based on the Lag phenotype
(larval arrest, absence of rectal and/or excretory cell, and a twisted
nose) (Lambie and Kimble, 1991).
Construction of plasmids
Deletions and mutations of sequence in the hlh-6 promoter were
cloned using standard procedures. hlh-6::YFP and enhancer constructs
are described elsewhere (Raharjo and Gaudet, 2007). Enhancer con-
structs were built using synthetic oligonucleotides that were cloned into
the promoterless GFP vector pPD95.77, kindly provided by Andrew Fire.
Details of plasmids and cloning strategies are available upon request.
For the enhancer constructs, we used the following inserts
(sequences of the individual motifs are capitalized):
3xLBS: cacGTGGGAAgcctcGTGGGAAgtcatGTGGGAAg
3 x P B S h l h : agcttccgatTGTTTGCacagccgatTGTTTGCacagccgat-
TGTTTGCacagcatg
3xPBSmix: agcttgctTGTTTGCtttcttataTGTTTGCcttgataggTGTTTGC-
caagcatg
3 x H R L 3 : aacCTGTTCAAAtgtatgaacCTGTTCAAAtgtatgaacCTGTT-
CAAAtg
The reporter hlh-6-mutLBS::YFP was generated by PCR-mediated
site-speciﬁc mutation (Ho et al., 1989) of predicted HRL/LAG-1 binding
sites. The engineered mutations are as follows (sequence changes are
underlined):
HRL1b: TGTCGGAAGC to TGAATTCAGC
HRL1c: GGTGGCTAAC to GGAAGCTTAC
HRL1d: TGTGGATAGT to TACTAGTTGT
Transgenics
hlh-6 reporter constructs were injected at 20 ng/μl together with two
transformation markers: 50 ng/μl pRF4 (rol-6(su1006)), which confers a
dominant Roller phenotype (Mello et al.,1991), and30ng/μl pJM67 (elt-2::
GFP::LacZ). Enhancer constructs were injected at 50 ng/μl with 40 ng/μl
pRF4 and 10 ng/μl ges-1::mRFP::HIS2B or elt-2::GFP::LacZ (Campbell et al.,
2002). The intestine-speciﬁc elt-2 and ges-1 reporters served as an
independent marker for transgenic arrays when scoring expression
(Fukushige et al.,1998); (Aamodtet al.,1991). Exceptions to these injection
conditions were constructs containing 3xPBS inserts, which appear to be
toxic at 50 ng/μl, and thuswere injected at 20 ng/μl togetherwith 50 ng/μl
pRF4 and30ng/μlelt-2::GFP-LacZorges-1::mRFP::HIS2B. For all constructs,
a minimum of two independent transgenic lines was analyzed.
Fig. 2. HRL1 responds to LAG-1 in vivo. (A) An enhancer construct containing PBS, three copies of HRL1 (GTCGGAA) and three copies of HRL2 is speciﬁcally expressed in pharyngeal
glands. (B) Three copies of a consensus LAG-1 binding site (3xLBS; GTGGGAA) can functionally replace three copies of HRL1 in a construct like that in panel A. (C) Removal of 3xHRL1
sequences results in broad expression throughout the posterior pharynx. (D) An enhancer construct containing three copies of PBS and three copies of HRL1 is expressed in
pharyngeal glands and pharyngeal neurons (arrowhead). (E) 3xLBS can functionally replace 3xHRL1, showing the same expression pattern as panel D. (F) Removal of HRL1 or LBS
results in expression throughout the pharynx. (G, H) lag-1 mutants have expanded expression of reporters, comparable to the removal of HRL1/LBS sequences. (I) Expression is
unaffected in lin-12 glp-1 mutants.
Table 1
Expression of HRL1-containing enhancer constructs in WT, lag-1 and lin-12 glp-1
zygotic mutants
Strain Reporter Expression⁎ n
Gland % Other %
N2 1xPBShlh+3xHRL1+3xHRL2 100 38 107
N2 1xPBShlh+3xLBS+3xHRL2 100 16 50
N2 1xPBShlh+3xHRL2 94 94 117
lag-1 1xPBShlh+3xHRL1+3xHRL2 100 69 82
lin-12 glp-1 1xPBShlh+3xHRL1+3xHRL2 100 40 33
N2 3xPBShlh+3xHRL1 100 38 58
N2 3xPBShlh+3xLBS 98 40 67
N2 3xPBShlh 97 97 47
lag-1 3xPBShlh+3xHRL1 97 97 62
⁎ Expression is reported as the percentage of transgenics with expression in the
indicated cells. “Other” indicates expression in addition to that seen in glands (for theﬁrst
ﬁve rows) or in cells other than pharyngeal glands and neurons (for the last four rows).
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RNAi was performed by microinjection. Young hermaphrodites
were injected with 1 μg/μL dsRNA produced by in vitro transcription
(T7 RiboMAX™ Express RNAi System, Promega) and the progeny
examined after 24 h.
DNA Binding
Electrophoretic mobility shift assays (EMSA) were performed as
described (Christensen et al., 1996). The 32P-labeled probes were
based on the HRL1b sequence from hlh-6: tgctaGTCGGAAgccgac
(HRL1b), tgctaGTGGGAAgccgac (LBS) and tgctaGGAAGCTgccgac (N.S.).
GST-LAG-1 (48–673) was produced from pJK947 (kindly provided by J.
Kimble), using methods described previously (Kovall and Hendrick-
son, 2004). EMSA reactions used 50 ng puriﬁed LAG-1 and 0.25 μg poly
(dI-dC) per reaction. Binding reactions were incubated for 30 min at
room temperature.
Ectopic expression of GLP-1(NICD)
The intracellular domain of the Notch ortholog GLP-1 (GLP-1
(NICD)) was ectopically expressed using the hsp::GLP-1(ANK) plasmid
pJK466 (kindly provided by J. Kimble) (Roehl and Kimble, 1993).
Independent transgenic strains were made for hsp::GLP-1(ANK) and
hlh-6::YFP and then crossed to generate doubly-transgenic animals.
Ectopic expression was induced in either late stage embryos
(N320 min post-fertilization) or in L1 larvae by incubation at 30 °C
for 5–7 h. Expression of the hlh-6 reporter was scored following heat
shock at regular intervals until animals reached late L4 to young adult
stages. Adults were examined for a multi-vulva (Muv) phenotype to
verify the activity of GLP-1(NICD).
Results
HRL1 is a LAG-1 binding site
The speciﬁc expression of hlh-6 in pharyngeal glands depends on
the combination of multiple cis-regulatory elements, including the
negative regulatory element, HRL1 (hlh-6 regulatory element 1; Fig.
1C; Raharjo and Gaudet, 2007). Previous work showed that mutation
of two HRL1 sequences (HRL1b and HRL1c) in the minimal 241 bp hlh-6 promoter (min-hlh-6) does not affect expression in the glands but
does result in weak ectopic reporter expression in larvae. In isolation,
three tandem copies of a HRL1 sequence have little or no activity in in
vivo enhancer assays, activating expression in occasional non-
pharyngeal neurons in a small fraction of transgenics. However,
when combined with positive HRL2 and PBShlh cis-regulatory elements
from the hlh-6 promoter, HRL1 functions to repress expression in non-
gland cells. These data indicate that HRL1 restricts hlh-6 expression to
pharyngeal glands by repressing expression outside of the glands. To
further elucidate the mechanisms controlling cell type-speciﬁc
expression of hlh-6, we sought to identify the trans-acting factor that
binds to HRL1.
The HRL1 sequences (1b: GTCGGAA and 1c: GTGGCTA) resemble,
but are not identical to, the consensus binding site for CSL transcription
factors (RTGGGAA; Brou et al., 1994; Christensen et al., 1996; Tun et al.,
1994) (Fig. 1D). Typically, CSL transcription factors act directly down-
stream of Notch signaling. In C. elegans, the sole CSL family member is
LAG-1 (Christensen et al., 1996); reviewed in (Greenwald, 2005). The
similarity of HRL1 to the LAG-1 binding site (LBS) raised the possibility
that hlh-6may be a direct target of LAG-1.
To test whether HRL1 was functionally equivalent to LAG-1
binding sites (LBS), we tested whether a consensus LBS could replace
HRL1 in enhancer assays. Our previous work showed that a single
copy of a PHA-4 binding site from the hlh-6 promoter (PBShlh)
Fig. 3. LAG-1 binds to HRL1 in vitro. (A, B) Electrophoretic mobility shift assay (EMSA) using LAG-1 and HRL1 probe (GTCGGAA), a consensus LBS probe (GTGGGAA) or a non-speciﬁc
probe (N.S.; GGAAGCT). Black arrowheads indicate shifted complex, open arrowheads indicate free probe. In panel A, cold competitor DNA is HRL1; in panel B, cold competitor is the
non-speciﬁc (N.S.) sequence.
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‘1xPBShlh+3xHRL1+3xHRL2’ construct) activates expression only in
pharyngeal glands (Fig. 2A; Raharjo and Gaudet, 2007). Similarly, the
combination of three copies of PBShlh and three copies of HRL1 (the
‘3x PBShlh+3xHRL1’ construct) activates expression in pharyngeal
glands and pharyngeal neurons (Fig. 2D). Removal or mutation of
HRL1 in these constructs results in broad expression in the pharynx
(Figs. 2C and F; Raharjo and Gaudet, 2007). We replaced the three
copies of HRL1 with three copies of the consensus LBS (3xLBS) in
these constructs and saw no apparent difference in expression (Figs.
2B and E; Table 1), indicating that LBS and HRL1 are functionally
interchangeable. These results suggest that HRL1 is a binding site for
the CSL transcription factor LAG-1.
We next determined that LAG-1 binds directly to HRL1 in vitro,
using electrophoretic mobility shift assays (EMSA). Puriﬁed LAG-1
protein was incubated with radiolabeled oligonucleotides containing
either the HRL1b sequence (GTCGGAA) or a consensus LBS
(GTGGGAA). Both sequences effectively bound to LAG-1 withFig. 4.Models for regulation of hlh-6 by LAG-1 and predictions of the effects in lag-1 and lin-
(LIN-12/GLP-1) signaling and LAG-1 in gland cells. (C) Indirect repression of hlh-6 in non-gl
activation of hlh-6, in which other transcription factors overcome repression by LAG-1 . Seecomparable afﬁnities (Fig. 3). Binding of LAG-1 to HRL1 is speciﬁc, as
binding of LAG-1 to LBS was competed by the addition of excess
unlabelled LBS or HRL1b sequence, but not by addition of a non-
speciﬁc competitor (N.S.: GGAAGCT). Together, our results indicate
that HRL1 sequences are binding sites for the CSL transcription factor
LAG-1.
HRL1/LBS repress expression of hlh-6 in non-gland cells
Since HRL1 functions as a LAG-1 binding site (LBS), we next
examined the function of LBS in regulating hlh-6. Based on the
established function of Notch signaling, a possible model for LAG-1
regulation of hlh-6 is shown in Figs. 4A and B. Typically, CSL
transcription factors in other systems function as default repressors
in the absence of Notch signaling (Fig. 4A), though a default repressor
role for LAG-1 has not been previously established. In the presence of
Notch signaling, LAG-1/CSL is converted from a repressor to an
activator (Fig. 4B). C. elegans LAG-1 is required for expression of12 glp-1mutants. (A) Direct repression in non-gland cells. (B) Direct activation by Notch
and cells. (D) Indirect activation in gland cells. (E) Notch-independent de-repression or
text for explanation.
Fig. 5.HRL1/LBS are required to repress non-gland expression of hlh-6. In panels A, B, the embryo and the developing pharynx are outlined. Strong nuclear expression posterior to the
pharynx in panel A is from the intestine-speciﬁc co-transformation marker. (A) Expression of the minimal hlh-6 promoter is ﬁrst detected in 1–2 gland cells (arrows) of mid-stage
embryos (11/2-fold embryo). (B) At the same stage, a promoter lacking HRL1/LBS (hlh-6-mutLBS) is expressed in glands and in several other cells bothwithin and outside the pharynx
(arrowheads). (C) Expression of hlh-6::YFP reporter with wild type HRL1/LBS. (D) Mutation of three HRL1/LBS in the minimal hlh-6 promoter does not affect expression in pharyngeal
glands (arrows) but results in ectopic expression in larvae (arrowheads).
Table 2
Expression of hlh-6 reporter in Notch loss- and gain-of-function mutants
Strain Reporter Expression n
Gland % Other %
N2 hlh-6 100 3 150
N2 larvae hlh-6-mutLBS 100 75 77
N2 embryos hlh-6-mutLBS 100 72 81
lag-1 (m+z-) hlh-6 100 63 82
lag-1(RNAi) hlh-6 94⁎ 82 33
lin-12 glp-1(RNAi) hlh-6 94⁎ 6 54
hsp::glp-1(NCID) hlh-6 100 6 48
lin-12 glp-1 (m+z-) hlh-6 100 54 91
⁎ The RNAi-treated embryos arrest prior to hatching with multiple developmental
defects, so expressing cells cannot be unambiguously identiﬁed as glands.
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a signiﬁcant decrease or loss of expression (Gupta and Sternberg,
2002; Neves et al., 2007; Yoo et al., 2004). Thus, one possibility is that
mutation of HRL1/LBS in the hlh-6 promoter would cause a loss of hlh-
6 expression. However, our previous analysis of the hlh-6 promoter
showed that removal of the two LBS/HRL1 sequences (HRL1b and
HRL1c) does not signiﬁcantly affect expression in pharyngeal glands,
but instead results inweak post-embryonic expression in cells outside
the pharynx (Raharjo and Gaudet, 2007). Therefore, either hlh-6
expression in glands does not require LBS or our previous analysis did
not remove all HRL1/LBS sequences from the hlh-6 promoter. Since
the two HRL1 sequences differ from the consensus LBS, we searched
the hlh-6 promoter for sequences that match a less stringent
consensus of RTNGNNA. This search identiﬁed an additional candidate
LBS at position -57 (relative to the ATG) that we named HRL1d
(GTGGATA, Fig. 1B). We then generated a new reporter, hlh-6-mutLBS::
YFP, inwhich all three possible HRL1/LBS (b, c and d) weremutated. As
with themutation of the two HRL1 sites, elimination of all three HRL1/
LBS sites did not affect expression in the pharyngeal glands (Fig. 5).
Mutation of all three HRL1 sites in hlh-6-mutLBS::YFP resulted in
substantial ectopic expression (Fig. 5). Most signiﬁcantly, mutation of all
three HRL1/LBS sites resulted in non-gland expression in 72% of
transgenic embryos (Table 2), which was not observed with previous
mutations in thehlh-6promoter (Raharjo andGaudet, 2007). Expression
of the wild type reporter is ﬁrst visible at mid-stage embryos (11/2-fold
to 2-fold embryos) in 1–2 gland cells; expression in other gland cells
becomes visible ∼1–2 h later (3-fold embryos) (Fig. 5A). At the same
developmental stage, the hlh-6-mutLBS reporter is expressed in
pharyngeal glands and in additional cells both within and outside the
developing pharynx (Fig. 5B). The ectopic pharyngeal expression is
largely conﬁned to the posterior region, consistent with the effect of
removing LBS from our enhancer constructs. Ectopic expression of hlh-
6-mutLBS is also observed post-embryonically, with 75% of transgenics
displaying non-pharyngeal reporter expression in 4–8 cells in the head
(Figs. 5C andD). These results suggest thatHRL1d is a functional LBS that is
partially redundantwithHRL1bandc. Furthermore, the threeHRL1/LBSact
to repress ectopic hlh-6 expression in non-gland cells and are dispensablefor activation of hlh-6 in glands, in contrast to the requirement for LBS in
expression of other LAG-1 C. elegans transcriptional targets.
lag-1, but not Notch signaling, is required for HRL1 activity in vivo
We next examined expression of HRL1-containing reporters in
lag-1 mutants and found that LAG-1 is required for HRL1 activity in
vivo. Since removal of HRL1/LBS results in ectopic hlh-6 expression,
removal of LAG-1 should have the same effect. We ﬁrst examined
expression of two of our enhancer constructs in lag-1 mutants:
1xPBShlh+3xHRL1+3xHRL2, which is normally expressed in phar-
yngeal glands, and 3xPBShlh+3xHRL1, which is normally expressed in
pharyngeal glands and neurons (Figs. 2A and D). We placed these
reporters in lag-1/+ animals and examined expression in lag-1
segregants, which arrest as early larvae (L1 stage). For both enhancer
constructs, gland expression was unaffected in lag-1 mutants,
indicating that LAG-1 is not activating gland expression. However,
lag-1 does have a role outside the glands because there was a
signiﬁcant increase in non-gland expression that phenocopies the
removal of HRL1 sites from these constructs (Fig. 2G and H, and Table
1). These results argue that lag-1 functions through HRL1 in vivo to
repress expression in non-gland cells (as in Fig. 4A) but that lag-1 is
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not seem to have a dual role as both a repressor and an activator as it
does in canonical Notch signaling.
Since LAG-1 is the downstream effector of Notch signaling in C.
elegans, we investigated whether repression through HRL1 required
Notch activity. Notch functions to convert LAG-1/CSL factors from
repressors to activators. However, as demonstrated above, since LAG-
1 does not appear to activate expression through HRL1, one
possibility is that Notch signaling is entirely dispensible for HRL1
function. Alternatively, the failure of lag-1 to inﬂuence gland
expression could be misleading: Notch signaling may be required
to lift repression of hlh-6 in glands, rather than activation per se
(leaving activation to other factors). In this scenario, when HRL1/LBS
or LAG-1 were removed there would no longer be a need to lift
repression in the glands, thereby circumventing a requirement for
Notch-dependent de-repression (Fig. 4B). In this latter model,
removal of Notch signaling would result in no gland expression
and so would differ from removal of HRL1/LBS. If Notch has no role in
gland de-repression, there would be no change when Notch signaling
is lost.
To address the potential role of Notch signaling in regulation of
hlh-6 expression, we examined the expression of our reporters in
mutants that lack Notch signaling. C. elegans has two partially
redundant Notch receptors, encoded by lin-12 and glp-1 (Austin and
Kimble, 1989; Lambie and Kimble, 1991; Yochem and Greenwald,
1989; Yochem et al., 1988). We therefore examined expression of our
1xPBShlh+3xHRL1+3xHRL2 enhancer construct in lin-12 glp-1 double
mutant segregants from lin-12 glp-1/+ +, which lack zygotic Notch
activity (Fig. 2I and Table 1). In these mutants, expression of the
enhancer construct was unaffected: gland expressionwas not reduced
nor was there any increase in non-gland expression. This resultFig. 6. LAG-1, but not Notch signaling, is required for repression of hlh-6. (A) Expression of a
unaffected, but some ectopic non-pharyngeal expression (arrowheads) is visible in an ar
(arrowheads). (C) lag-1(RNAi) embryo expressing the gland-speciﬁc marker B0507.1::GFP::H
embryo, both hlh-6 (D) and B0507.1 (E) reporter expression were unaffected and only obse
expressing GLP-1(NICD) under the control of a heat-shock inducible promoter. (G) Expressi
glands (arrow) is unaffected, but some ectopic expression (arrowhead) is visible. (H) Expr
presence of a gland-like cell outside the pharynx (arrowhead).demonstrates that, in contrast to the role of LAG-1, LIN-12/GLP-1 are
not required for HRL1 activity in our enhancer constructs.
Because the enhancer constructs may not fully recapitulate all
aspects of the hlh-6 promoter, we also examined expression of the
intact hlh-6 promoter construct in lag-1 mutants. In embryos from
lag-1/+ mothers, gland expression was unaffected and we observed
ectopic expression in 63% of arrested lag-1 larvae (Fig. 6A and Table 2).
The ectopic expressionwas not as extensive as that observed when all
HRL1/LBS were mutated in the hlh-6 promoter (Table 2; Fig. 5). One
possible explanation is that maternally contributed lag-1(+) functions
to prevent non-gland expression of hlh-6 while the HRL1 mutants
would be equivalent to loss of both maternal and zygotic lag-1 inputs.
To test the possible role of maternal lag-1(+), we performed RNA-
mediated interference (RNAi) against lag-1 to deplete both maternal
and zygotic transcripts and then scored hlh-6 reporter expression in
the affected embryos. lag-1(RNAi) embryos arrested with severe
malformations, as expected, indicating successful RNAi treatment.
lag-1(RNAi) embryos expressed the hlh-6 reporter in an average of 7–8
cells (Fig. 6B).Wild type embryos have only ﬁve gland cells, suggesting
that hlh-6 expression is expanded in lag-1(RNAi) embryos. Further-
more, 3–4 of the expressing cells appeared to be pharyngeal glands, as
they had small projections and are clustered together in the embryo.
The remaining cells that expressed hlh-6were located in other regions
of the embryo and do not exhibit gland-like projections, suggesting
that while they express hlh-6, their identity has not been altered to a
gland-like fate. Consistent with this interpretation, expression of
another marker of pharyngeal glands (B0507.1::GFP::HIS2B; Smit and
Gaudet, in preparation) is not expanded in lag-1(RNAi) embryos and is
conﬁned to 4–5 gland-like cells (Fig. 6C). Ectopic expression of hlh-6 in
lag-1(RNAi) is therefore not coupled to an alteration in cell identity
(consistent with our unpublished observations that hlh-6 is notn hlh-6::YFP reporter in a lag-1 segregant. Expression in pharyngeal glands (arrows) is
rested lag-1 larva. (B) lag-1(RNAi) embryo showing ectopic expression of hlh-6::YFP
IS2B. No ectopic expression was observed. (D, E) In a lin-12(RNAi) glp-1(RNAi) affected
rved in 4–5 gland-like cells (arrows). (F) Expression of hlh-6 is unaffected in animals
on of an hlh-6::YFP reporter in zygotic lin-12 glp-1 segregant. Expression in pharyngeal
ession of the gland marker B0507.1::GFP::HIS2B in lin-12 glp-1 mutants indicates the
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and likely reﬂects a direct effect on the hlh-6 promoter. Together, these
data suggest that lag-1 is not required for hlh-6 expression in glands,
but functions to repress its expression in non-gland cells.
We next examined activity of the hlh-6 promoter in lin-12 glp-1
animals. As with lag-1, lin-12 and glp-1 activity are maternally
contributed. Therefore, to reduce both maternal and zygotic
transcripts, we performed RNAi against both lin-12 and glp-1. RNAi
resulted in embryonic arrest, as expected for the removal of Notch
activity, but we consistently observed expression of the hlh-6
reporter in only 3–5 cells that resemble glands (Fig. 6D and Table
2). As with the gland-like cells in lag-1(RNAi) embryos, the
expressing cells in lin-12 glp-1 typically had short projections and
were clustered together. Expression of another gland marker
(B0507.1::GFP::HIS2B) was similarly restricted to 4–5 gland-like
cells in lin-12 glp-1(RNAi) embryos, supporting the hypothesis that
gland development was unaffected (Fig. 6E). The presence of hlh-6
expression in 3–5 cells of lin-12 glp-1(RNAi) embryos argues that
Notch signaling is neither required for activation of hlh-6 in glands
nor for repression in non-gland cells. Therefore, while LAG-1 directly
represses hlh-6, LIN-12/GLP-1 is not required for this repressor
activity.Fig. 7. Identiﬁcation of HRL3. (A) Three copies of the PBS from hlh-6 (PBShlh) activate expres
(arrowheads). (B) Three copies of PBS with random ﬂanking sequence (PBSmix) shows little o
marker. (C) Three copies of PBSmix with three copies of HRL2 activates expression in the poste
3xHRL3 restores expression in pharyngeal glands (arrows). (E) Mutation of HRL3 sequence
graphs represent the percentage of transgenic animals with gland-expressed YFP. Black rep
observable expression.Signaling through Notch results in proteolytic release of the Notch
intracellular domain (NICD), which then enters the nucleus to convert
CSL into a transcriptional activator. As an additional test of whether
hlh-6 expression is responsive to Notch, we expressed the NICD of
GLP-1 under the control of a heat-shock promoter (Roehl and Kimble,
1993) and assayed the effect on hlh-6::YFP expression. If hlh-6 is
responsive to Notch signaling, ectopic expression of GLP-1(NICD)
should result in ectopic expression of hlh-6::YFP. However, none was
observed (Fig. 6F and Table 2), although these animals did display a
multi-vulva (Muv) phenotype in later stages, consistent with the
effects of ectopic activation of Notch signaling (Greenwald et al., 1983;
Mango et al., 1991; Roehl and Kimble, 1993). Thus, Notch signaling is
not sufﬁcient for activation of hlh-6 expression, either because hlh-6 is
not responsive to Notch signaling or because necessary co-factors for
hlh-6 expression are not present in the cells that express GLP-1(NICD).
Zygotic Notch signaling indirectly regulates hlh-6 expression
While Notch signaling is not required for most aspects of hlh-6
expression, zygotic Notch does appear to indirectly repress hlh-6
expression in larvae. We examined hlh-6 expression in lin-12 glp-1
double mutants from lin-12 glp-1/++ mothers and again found thatsion throughout the pharynx, with stronger expression in glands (arrows) and neurons
r no activity. Expression posterior to the pharynx is from the elt-2::GFP::LacZ transgenic
rior pharynx, but not in glands (arrows). (D) Three copies of PBSmix with three copies of
(black rectangle) in the minimal hlh-6 promoter signiﬁcantly reduces expression. Bar
resents strong expression, grey represents weak expression, and white represents no
Table 3
Expression of enhancer constructs
Construct Expression (% expressing transgenics) n
No enhancer None (0%) N50
3xPBShlh Pharynx (97%) 47
3xPBSmix Pharynx (14%) 42
1xPBSmix+3xHRL2 Posterior pharynx (non-gland cells only; 86%) 81
3xHRL3 None (0%) 30
3xPBSmix+3xHRL3 Pharynx, including glands (53%); pharynx, non-gland (33%) 45
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ectopic hlh-6 expression in cells outside the pharynx, similar to what
we observed in lag-1 zygotic mutants (Fig. 6G and Table 2). The simple
interpretation of this result is that zygotic LIN-12/GLP-1 and zygotic
LAG-1 are required for repression of hlh-6 in some post-embryonic
cells. Given the known function of Notch in converting CSL/LAG-1 to
an activator, Notch signaling must be indirectly repressing hlh-6 in
this case, presumably by activating an inhibitor that normally
prevents expression in the ectopic cells. This interpretation is based
on the three possible models for regulation of hlh-6 by LIN-12/GLP-1:
direct activation, indirect repression or indirect activation (Figs. 4B–
D). Only in the case of indirect regulation does a loss of Notch signaling
(or loss of LAG-1) lead to ectopic hlh-6 expression in non-gland cells
(Fig. 4C), as we observe. This indirect regulation is distinct from the
situation in which both maternal and zygotic components are
removed by RNAi. There loss of lag-1 resulted in ectopic hlh-6
expression, while loss of lin-12 glp-1 had no effect. These ﬁndings
suggest that Notch signaling does not affect embryonic hlh-6
expression but that later (at a developmental stage after the RNAi-
treated embryos arrest) Notch signaling indirectly represses hlh-6,
possibly reﬂecting a role for Notch signaling in speciﬁcation of non-
gland cell fates. Accordingly, the gland marker B0507.1::GFP is
expressed in 1–2 non-pharyngeal cells in the heads of lin-12 glp-1
mutants, suggesting that these cells have altered cell identity (Fig. 6H).
The differing requirement for Notch in direct and indirect regulation
of hlh-6 is consistent with the fact that Notch signaling is used
repeatedly in different cell fate decisions throughout development
(Priess, 2005).
Activation of hlh-6 expression in pharyngeal glands requires three
different inputs
If the only role of LAG-1 is to repress hlh-6, then how is this
repression overcome in pharyngeal glands, where hlh-6 is expressed
(Fig. 4E)? Since LIN-12/GLP-1 are not involved in direct regulation of
hlh-6 expression, there must be some other explanation for the
activity of the hlh-6 promoter in pharyngeal glands. One possibility is
that LAG-1 is not present in pharyngeal glands, though expression
analysis indicates that LAG-1 is ubiquitous during embryonic devel-
opment (J. Kimble, personal communication). Another possibility is
that transcriptional activators present in the glands are sufﬁcient to
overcome repression by LAG-1. Both PBS and HRL2 are required for
expression of hlh-6 in glands, yet these inputs alone are not sufﬁcient
to overcome LAG-1, as their activity in non-gland cells is repressed by
LAG-1. There must therefore be some other factor(s) that function
(alone or in combination with PHA-4 and the HRL2-binding factor) to
overcome repression by LAG-1, thus allowing hlh-6 to be expressed in
the pharyngeal glands.
We reasoned that any additional elements required for gland
expression of hlh-6 must be present in our 1xPBShlh + 3xHRL1 +
3xHRL2 enhancer construct, as this combination of elements is
expressed in pharyngeal glands. Similarly, our 3xPBShlh + 3xHRL1
and 1xPBShlh + 3xHRL2 constructs are expressed in pharyngeal glands,
although not speciﬁcally (Raharjo and Gaudet, 2007). These results
suggest that the PBShlh sequence may contain additional cis-
regulatory information that is required for expression in pharyngeal
glands.We therefore designed a construct that would respond to PHA-
4 but in which any other regulatory information was removed. The
resulting construct (3xPBSmix) contains three PBS with the same core
sequence (TGTTTGC) but with three different ﬂanking sequences,
corresponding to the ﬂanking sequence from three functionally
veriﬁed PBS’s (from T05E11.3, ceh-22 and C44H4.1; (Gaudet and
Mango, 2002; Overdier et al., 1994); see Materials and Methods for
sequence details). The 3xPBShlh construct activates reporter expres-
sion in multiple pharyngeal cells and frequently produces more
intense signal in glands and neurons than other pharyngeal cell types(Fig. 7A and Table 3). In contrast, 3xPBSmix shows signiﬁcantly less
activity and is not active in pharyngeal glands (Fig. 7B and Table 3),
suggesting that sequence ﬂanking the core PBS is required for
expression in glands.
Two explanations could account for the inﬂuence of sequence
ﬂanking the PBS. First, sequence ﬂanking the PBS could affect the
afﬁnity of PHA-4, as ﬂanking bases are known to affect the binding of
the Drosophila ortholog forkhead to target sites (Takiya et al., 2003). A
second possibility is that the sequence ﬂanking the PBS could
represent a binding site for a second factor, as is the case in the
PHA-4 target gene myo-2, where the PBS overlaps with a binding site
for the transcriptional regulator PEB-1 (Kalb et al., 2002; Thatcher et
al., 2001). We therefore tested additional enhancer constructs to
distinguish between the two possibilities, to see if we could separate
out a second enhancer activity within the PBS sequence we had been
using. First, we constructed a 3xPBSmix + 3xHRL2 construct and found
that this construct was expressed in posterior pharyngeal cells (Fig.
7C), suggesting that 3xPBSmix continues to be responsive to PHA-4.
However, expression is notably absent from the pharyngeal glands,
suggesting that the altered PBS sequence speciﬁcally affects gland
expression. This ﬁnding supports the hypothesis that the activity of
PBShlh reﬂects more than just the activity of PHA-4. We therefore
tested whether PBShlh contained a cis-regulatory element in addition
to the core PBS. We designed a construct including this new element
without the PBS, 3xHRL3, that contains most of the sequence of
3xPBShlh but with the core PBS disrupted (CATTTGAACAG, identity to
3xPBShlh underlined). On its own, 3xHRL3 has no enhancer activity
(Table 3). However, the combination of 3xPBSmix and 3xHRL3 resulted
in signiﬁcant expression in pharyngeal cells, including the pharyngeal
glands (Fig. 7D and Table 3), comparable to that seen with 3xPBShlh.
Because the two components can be separated and re-combined in
this manner, we propose that 3xPBShlh contains two cis-regulatory
elements: a core PBS and a previously unidentiﬁed regulatory
element, HRL3, which is required for expression of hlh-6 in pharyngeal
glands.
We also testedwhether HRL3 is functionally relevant in the context
of the hlh-6 promoter, rather than just in enhancer constructs. We
generated reporters in which sequence ﬂanking the core PBS of hlh-6
was altered to resemble sequence from other functionally veriﬁed PBS
(ΔHRL3-1: myo-2, ΔHRL3-2: ceh-22) or was random (ΔHRL3-3 and
ΔHRL3-4). In all four cases, the mutation drastically reduced or
eliminated expression, indicating that HRL3 is important for expres-
sion of hlh-6 in pharyngeal glands (Fig. 7E). We propose that the
combined action of PHA-4 and factors acting through HRL2 and HRL3
overcome repression by LAG-1 in pharyngeal glands to activate
expression of hlh-6.
Discussion
Here we present evidence that hlh-6 is directly regulated by the
C. elegans CSL transcription factor LAG-1. Two interesting features
of hlh-6 regulation by LAG-1 are that LAG-1 acts through non-
consensus sites in the hlh-6 promoter and that LAG-1 appears to
function solely as a default repressor, independent of Notch
signaling. We further demonstrate that a newly identiﬁed cis-
regulatory element, HRL3, is required for expression of hlh-6 in
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acts in place of Notch signalling to overcome LAG-1 repression in the
gland cells.
Identiﬁcation of non-consensus LAG-1 binding sites in the hlh-6
promoter
Our analysis suggests that there are three distinct HRL1 sequences
in the hlh-6 promoter that function as LAG-1 binding sites (LBS; Fig. 1).
These sites are required to restrict expression of hlh-6 to pharyngeal
glands, as mutation of the sites results in ectopic expression. HRL1 can
be replaced by a consensus LBS, indicating that the different
sequences are functionally equivalent (Figs. 2A–F). In addition, LAG-
1 binds to these sites in vitro (Fig. 3) and is required for their activity in
vivo (Figs. 2G and H), demonstrating that the HRL1 sequences are
genuine LBS, despite their divergence from the consensus LAG-1
binding site. The functional relevance of these sequences is also
supported by the observation that at least one of the HRL1/LBS
sequences is conserved between nematode species. Previously, we
showed that HRL1b is conserved in C. briggsae (Raharjo and Gaudet,
2007). We also ﬁnd HRL1b is conserved in the promoters of hlh-6 from
C. remanei and C. brenneri (Fig. 1E), which we identiﬁed using available
genomic tools (Dieterich and Sommer, 2008). HRL1c and 1d are not
consistently found in the promoters from all four species. However,
each promoter contains at least one other HRL1/LBS sequence (data
not shown), suggesting that these sequences function redundantly as
they do in the C. elegans hlh-6 promoter.
Based on our results, we propose that LAG-1 recognizes a broader
consensus sequence of RTSGNWA, rather than the more stringent
RTGGGAA sequence. The C. elegans results differ from that in other
organisms, as studies of Drosophila Su(H) and mammalian RBP-Jk
binding preferences indicate that alterations of the GTGGGAA
sequence to GTGGCAA or GTGGGTA substantially reduce or eliminate
binding in vitro (Brou et al., 1994; Tun et al., 1994). However, non-
consensus binding sites for the CSL family member CBF-1 have been
identiﬁed, suggesting that some family members have differing
binding preferences or stringencies (Tyagi and Karn, 2007). Binding
preferences for C. elegans LAG-1 have not been rigorously tested and
our results suggest that the protein has a broader consensus than its
orthologs.
A Notch-independent role for LAG-1 in gland fate speciﬁcation
CSL transcription factors typically function downstream of Notch
signaling: in the absence of signaling, the factors act as default
repressors, while active signaling switches the factors to be activators.
In C. elegans, LAG-1 is known to activate gene expression, though no
repressive role was previously established. Our ﬁnding that HRL1/LBS
function to prevent expression of hlh-6 outside the pharyngeal glands
is consistent with LAG-1 functioning as a default repressor, similar to
the behavior of other CSL family members. However, in contrast to
typical regulation by LAG-1/CSL, Notch signaling does not convert LAG-
1 froma repressor to an activator and instead appears to be dispensable
for hlh-6 expression. Four lines of evidence support the argument:
ﬁrst, removal of all possible LBS from the hlh-6 promoter does not
reduce expression (Fig. 5), while removal of LBS from other Notch
targets reduces or abolishes expression (Gupta and Sternberg, 2002;
Neves et al., 2007; Yoo et al., 2004). Second, HRL1/LBS do not appear to
stimulate expression in pharyngeal glands in our in vivo enhancer
assays and instead only act as repressors of expression (for example,
compare the activity of 3xPBShlh to that of 3xPBShlh+3xHRL1; Fig. 2).
Third, loss of lag-1 phenocopies the loss of inhibitory activity seenwith
the removal of the HRL1 elements from reporters but does not reduce
(or in anywayaffect) expression in pharyngeal glands (Figs. 2, 5 and 6),
indicating a lack of activator function. Fourth, removal of Notch
signaling in lin-12 glp-1 (RNAi) animals has no positive or negativeeffect on hlh-6 expression in pharyngeal glands (Fig. 6C) and zygotic
removal of lin-12 glp-1 does not affect HRL1 activity in enhancer
constructs (Fig. 2I). These ﬁndings suggest that LAG-1 acts only to
repress hlh-6 in non-gland cells. One caveat to our interpretation of
these results is that lin-12 glp-1 (RNAi) may not completely deplete
Notch activity, leaving open the possibility that Notch signaling is
required for de-repression (but not activation) of hlh-6 in pharyngeal
glands.
There are other examples of Notch-independent roles for CSL
proteins during development. In Drosophila bristle socket cell
development, Su(H) functions as a Notch-independent repressor of
E(spl) expression, though Su(H) is still converted to be an activator
of gene expression in other cells (Barolo et al., 2000). Similarly, Su(H)
can act as both an auto-repressor and as an auto-activator indepen-
dent of Notch (Klein et al., 2000; Koelzer and Klein, 2003). Likewise,
vertebrate CSL proteins can function as activators independent of
Notch signaling (Ito et al., 2007; Masui et al., 2007). In contrast, both
Notch signaling and LAG-1 are dispensable for activation of hlh-6
expression, suggesting a novel use of LAG-1 as a default repressor to
prevent expression outside of the desired cell population. This strict
repressor role for LAG-1 does not appear to be a conserved feature of
foregut gland development. CSL family members play a role in foregut
gland development in other species, but appear to function primarily
as activators of target gene expression: Drosophila salivary gland
development requires active Notch signaling (Haberman et al., 2003),
while formation of pancreatic glands in mice involves a Notch-
independent CSL activator (Masui et al., 2007).
Notch signaling is neither necessary nor sufﬁcient (when driven by
the heat-shock promoter) for hlh-6 expression, suggesting that the
gene is unresponsive to Notch. The lack of such a response, despite the
presence of LBS, is consistent with observations that activation by
Notch/CSL alone is not sufﬁcient for target gene activation in other
systems, instead requiring additional factors acting in combination
with CSL. Such "Notch transcriptional codes" have been described for
some target genes, in which CSL binding sites are paired in close
proximity to binding sites for other activators (Cave et al., 2005; Guss
et al., 2001; Neves et al., 2007). Furthermore, activation through those
sites may depend on physical interactions between CSL and co-
activators. Interestingly, in the hlh-6 promoter, we observe close
pairing of LBS with the HRL2 activator elements, yet see no synergistic
activation by LBS and HRL2, either in the hlh-6 promoter or in
enhancer constructs. One possibility is that hlh-6 is unresponsive to
Notch because other activators of hlh-6 (e.g. the factor acting through
HRL2) do not physically interact with LAG-1.
We note that the ectopic expression resulting from the mutation of
HRL1/LBS in the intact hlh-6 promoter is not equivalent to the ectopic
expression obtained when HRL1 is removed from our enhancer
constructs (compare Figs. 2C and 5D). These differences are not
surprising given the arbitrary architecture of the enhancer construct
and indicate that while the combination of 1xPBShlh+3xHRL1+3xHRL2
contains the necessary elements to recapitulate gland-speciﬁc expres-
sion of hlh-6, it is not an exact replica of the hlh-6 promoter. Speciﬁcally,
the enhancer construct differs from the hlh-6 promoter with respect to
the number, spacing and position (relative to each other and the
transcription start site) of cis-regulatory elements. Furthermore, the
hlh-6 promoter may contain additional cis-regulatory elements that,
while not required for expression in glands, may inﬂuence the activity
of the promoter in the absence of regulation by HRL1. The important
point, however, is that removal of LBS and removal of lag-1 result in the
same ectopic expression for a given reporter.
HRL3 is a distinct cis-regulatory element required for hlh-6 expression
We have identiﬁed a new regulatory element that overcomes
LAG-1 repression in place of Notch signaling. Activation of hlh-6
requires three distinct regulatory elements: PBS, HRL2 and the newly
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factors may indirectly prevent repression by LAG-1 or a single factor
may act directly on LAG-1 to de-repress hlh-6 expression; we cannot
currently distinguish between these two models.
We did not previously identify HRL3 as a distinct element because
it lies in close proximity to the PBS and was therefore present in all of
our previously tested enhancer constructs. In this study, we were able
to physically separate the PBS and HRL3 components, demonstrating
that they are distinct cis-regulatory elements (Fig. 7). As deﬁned by
our analysis, HRL3 is either immediately adjacent to or overlapping
with the PBS. This close proximity may reﬂect a physical interaction
between PHA-4 and the factor that functions through HRL3, or may
indicate competition for or sequential occupation of the DNA. Notably,
competition between PHA-4 and the transcriptional regulator PEB-1
has been reported to take place at two overlapping sites in the
promoter of C. elegans myo-2 (Kalb et al., 2002), providing a
precedence for the overlap of PBS with another transcription factor
binding site. Whether regulation of hlh-6 involves a similar competi-
tion of factors remains to be seen. Searches for possible trans-acting
factors for HRL3 using TESS (Schug, 2003) did not yield any promising
candidates.
Our results provide an expanded model for regulation of hlh-6, in
which PBS, HRL2 and HRL3 are required for activation in gland cells
and HRL1/LAG-1 acts as a repressor in non-gland cells. A simple
interpretation of the results suggests that expression of hlh-6 is
dictated by the overlapping activity of the three positive regulatory
inputs: PBS is active in the pharynx, HRL2 in MS-derived/posterior
cells and HRL3 in neurosecretory cells. The overlapping activity of all
three elements appears to specify expression in the pharyngeal
glands, though overlap of any two may be sufﬁcient to provide weak
expression in non-gland cells. The role of HRL1/LAG-1would therefore
be to repress any such "leaky" expression of hlh-6 outside of the
desired cell population.
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